“Rhetorical Capture”

Margaret Jane Radin
  • Intellectual Property and Antitrust
Arizona Law Review
2012

“Tying and Consumer Harm”

Daniel A. Crane
  • Intellectual Property and Antitrust
Competition Policy International
2012

“A Neo-Chicago Perspective on Antitrust Institutions”

Daniel A. Crane
  • Intellectual Property and Antitrust
Antitrust Law Journal
2012

“Copyright Exhaustion and the Personal Use Dilemma”

Aaron Perzanowski
  • Intellectual Property and Antitrust
  • Health Law
Minnesota Law Review
2012

“IP’s Advantage Over Antitrust”

Daniel A. Crane
  • Intellectual Property and Antitrust
The Global Limits of Competition Law
2012

“Antibiotic Resistance”

Jessica Litman
  • Intellectual Property and Antitrust
Cardozo Arts & Entertainment Law Journal
2012

“Wisdom of the Ages or Dead-Hand Control? Patentable Subject Matter for Diagnostic Methods After In Re Bilski”

Rebecca S. Eisenberg
  • Intellectual Property and Antitrust
Case Western Reserve Journal of Law, Technology & the Internet
2012

The Making of Competition Policy: Legal and Economic Sources

Daniel A. Crane
  • Intellectual Property and Antitrust
2012

“Were Standard Oil’s Railroad Rebates and Drawbacks Cost Justified?”

Daniel A. Crane
  • Intellectual Property and Antitrust
Southern California Law Review
2012

“The Obama Justice Department’s Merger Enforcement Record: An Armchair Reply to Baker and Shapiro”

Daniel A. Crane
  • Intellectual Property and Antitrust
Stanford Law Review Online
2012

“Search Neutrality as an Antitrust Principle”

Daniel A. Crane
  • Intellectual Property and Antitrust
George Mason Law Review
2012

“Search Neutrality and Referral Dominance”

Daniel A. Crane
  • Intellectual Property and Antitrust
Journal of Competition Law & Economics
2012

“Has the Obama Justice Department Reinvigorated Antitrust Enforcement?”

Daniel A. Crane
  • Intellectual Property and Antitrust
Stanford Law Review Online
2012

“Patents and Regulatory Exclusivity”

Rebecca S. Eisenberg
  • Intellectual Property and Antitrust
The Oxford Handbook of the Economics of the Biopharmaceutical Industry
2012